Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids
Open Access
- 25 September 2022
- journal article
- research article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 13 (1) , 82-99
Abstract
No abstract availableKeywords
Funding Information
- Centro para el Desarrollo Tecnológico Industrial (IDI-20130943, IDI-20150915)
This publication has 113 references indexed in Scilit:
- Sigma-1 receptor antagonism as opioid adjuvant strategy: Enhancement of opioid antinociception without increasing adverse effectsEuropean Journal of Pharmacology, 2013
- Potentiation of morphine-induced mechanical antinociception by σ1 receptor inhibition: Role of peripheral σ1 receptorsNeuropharmacology, 2013
- A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with MorphineThe Journal of Pharmacology and Experimental Therapeutics, 2013
- Understanding the Effect of Different Assay Formats on Agonist Parameters: A Study Using the µ-Opioid ReceptorSLAS Discovery, 2011
- The sigma-1 receptor chaperone as an inter-organelle signaling modulatorTrends in Pharmacological Sciences, 2010
- σ1 Receptor Modulation of G-Protein-Coupled Receptor Signaling: Potentiation of Opioid Transduction Independent from Receptor BindingMolecular Pharmacology, 2010
- Targeting sigma receptors: novel medication development for drug abuse and addictionExpert Review of Clinical Pharmacology, 2009
- Activation of the spinal sigma‐1 receptor enhances NMDA‐induced pain via PKC‐ and PKA‐dependent phosphorylation of the NR1 subunit in miceBritish Journal of Pharmacology, 2008
- NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticityBrain Research Reviews, 1999
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983